TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
CLDX

Celldex Therapeutics Inc

Healthcare · Biotechnology

31.10$ -7.1% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Celldex Therapeutics Inc (CLDX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 782 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CLDX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
280 466 869 846 823 792 739 692 648 583 511 782
246 432 835 812 779 747 694 648 604 535 459 725
21 35 115 43 36 28 17 23 36 29 36 47
235 422 824 802 756 725 673 630 583 519 451 718
0.3 4.5 2.7 1.5 0.9 0.7 1.1 0.1 0.1 2.0 0.2 0.2
0.0 0.0 0.0 – – – – – – – – –
27 27 27 27 27 27 27 27 27 27 27 27
34 36 30 32 37 45 36 37 50 56 55 68
28 31 26 28 32 40 32 33 46 51 51 61
1.5 1.6 1.6 1.6 1.4 1.5 1.5 1.5 1.6 1.6 1.5 1.6
3.6 3.5 3.2 3.8 1.1 3.3 3.4 2.1 4.3 1.2 10 15
247 429 839 814 786 747 703 655 598 527 456 715
-1,354 -1,397 -1,430 -1,466 -1,508 -1,555 -1,609 -1,666 -1,733 -1,814 -1,893 -1,966
47 52 59 66 66 66 66 66 66 67 67 78

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?